Need for medicine-related data increases, the system responds to the change slowly
It would be useful to have RWE support the decision-making related to managed introduction and...
It would be useful to have RWE support the decision-making related to managed introduction and...
In health economic studies, real world evidence (RWE) can produce additional knowledge, especially on the...
The basic reimbursement granted for medicinal substance teduglutide was a significant step forward for children...
The study assessed the prevalence of Gaucher disease in Finland and developed methods to screen...
Recently, there has been a lot of discussion on virtual control arms. In this blog...
We already have clinical medicine trials. Why on earth do we also need real world...
Chronic kidney disease has been suggested as the main contributor to the increased cardiovascular morbidity...
Planning of a medicines data repository compiling different data sets is well underway, which is...
Utilisation of real-world evidence (RWE) progresses at speed and development steps are fast. Utilising real-world...
Studies relying on real-world evidence help clinicians to create a better overall picture of the...
The results of studies based on real-world data (RWD) have convinced also people that were...
Last summer the readers of my blog guessed that the number of real-world evidence (RWE)...
The safety and efficacy of pharmacotherapy can be measured in multiple ways during the different...
RWE or real-world evidence provides authorities assessing pharmacotherapies with data on the prevalence of a...
Randomized clinical trials (RCT) have traditionally been held up as the gold standard for studying...
Health economic evaluations bring additional information to the authorities’ decision-making concerning medicinal products. How does...
From the perspective of decision-making, it is important that a health economic evaluation conducted on...
Cardiovascular diseases are the leading cause of disability and premature death worldwide. Real-world evidence (RWE)...
HUS Pharmacy Director Kerstin Carlsson reveals the process of national price negotiation of hospital-only medicinal...
Real-world data on diffuse large B-cell lymphoma (DLBCL) has remained incomplete. In Finland, electronic health...
We start this year in the world of methodologies with a hot topic of utilizing...
Medaffcon expands its network of companies to Omicron ApS and Value Coaching Oy to extend...
With the ninth Health from Data blog post and the end of the year closing...
A real-world evidence (RWE) study makes visible what happens to a group of patients in...
We took the first glimpse into the world of methodologies earlier this year when Medaffcon’s...
The Finnish health and social care registries are unique from an international perspective. Thus, real-world...
Research has shown that osteoarthritis causes disability, especially among older adults. Our latest real-world evidence...
Real-world evidence (RWE) is relatively young. However, RWE-research has its roots in the traditional registry-based...
OSLO, Norway/ ESPOO, Finland May 24, 2021 LINK Medical, the Northern European clinical research organization...
This series of featuring blog posts aims to open the world of data analysis methodologies....
DLIMI and Medaffcon join forces to provide research-based pharmaceutical companies with Nordic Real World Evidence...
Multiple myeloma (MM) is a hematologic cancer displaying an abnormal heterogenous B cell population in...
Real-world evidence is gaining interest – and fast. The phenomenon is global. The growth of...
A prototype of a Gaucher disease point-scoring system (PSS), originally established by the Gaucher Earlier...
Year 2021 will be the year of Real-World Evidence. Data obtained from patients’ treatment has...
This March marks the start of my new blog – Health From Data. Here I...
Interested in RWE research? Health from data is the first real-world evidence themed blog written...
Real World Evidence (RWE) ecosystem in Finland Real world data (RWD) is defined by FDA...
Medicines in Finland are divided into medicines in ambulatory and hospital care. This article describes...
Migraine is a disabling headache disorder that places a significant burden both for the patients...
The real world data (RWD) landscape in Finland offers globally unique data and possibilities to...
The proportion of patients hospitalized for heart failure (HF) with preserved left ventricular ejection fraction...
A unique study on the treatment results of migraine patients led Terveystalo to develop the...
In migraine, co-occurrence of two or more diseases or conditions is typical. Asthma and allergies,...
A new real world evidence study on Idiopathic pulmonary fibrosis (IPF) describes the high disease...